The program, called BioMe, uses a new platform called “Clinical Implementation of Personalized Medicine through Electronic Health Records and Genomics” or CLIPMERGE to communicate with the EMR and give physicians real-time guidance based on a patient’s genetic profile. Currently, real-time feedback for therapies, based on DNA, is only available for cardiovascular disease, blood clots and high cholesterol.
More Articles on Mount Sinai Medical Center:
Mount Sinai Medical Center Promotes Alex Mendez to Executive VP, CFO
Mount Sinai Medical Center Unveils $440M Hess Center, New Logo
Spreading Ideas About Healthcare’s Future: Q&A With Dr. Kenneth Davis, President and CEO of The Mount Sinai Medical Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
